Depression
News, opinions and meeting coverage in psychiatry.
<ѻý>APA Meeting Highlights Mental Health Biologyѻý>
NEW YORK CITY -- The biological basis for normal and abnormal mental function is emerging as a dominant theme in psychiatry research, and the American Psychiatric Association annual meeting that starts here Saturday won't be an exception.
May 01, 2014
<ѻý>Lab Notes: Red Wine Before Radiation and Red Clover for Hair Lossѻý>
Red is the color of the day, as components of red wine and red clover lead this week's Lab Notes, but the blues get their turn in the spotlight, too, as depressed people outshine cheerier folks in some elements of decision making.
May 06, 2011
<ѻý>FDA Panel: Keep ECT Devices as High Riskѻý>
GAITHERSBURG, Md. -- The FDA should continue to regulate electroconvulsive therapy (ECT) machines as high-risk devices for treating depression and most other conditions for which ECT is typically used, members of the agency's Neurological Devices Advisory Committee agreed.
Jan 28, 2011
<ѻý>Grief Following Death in the Family Ebbs in Six Months
ѻý>
NEW HAVEN -- The negative emotions of grief -- yearning, depression, and anger -- following the death of a family member from natural causes usually peak within six months, according to a Yale bereavement study of 233 mourners
Feb 21, 2007
<ѻý>FDA Warns on Mixing Antidepressants with Migraine Drugs
ѻý>
ROCKVILLE, Md. -- Mixing common migraine drugs such as Imitrex (sumatriptan) with antidepressants like Prozac (fluoxetine) or Cymbalta (duloxetine) can trigger a life-threatening condition called serotonin-syndrome, the FDA has warned.
Jul 20, 2006
<ѻý>FDA Approves First Antidepressant Transdermal Patchѻý>
ROCKVILLE, Md. - The FDA has approved a once-a-day antidepressant patch that delivers a monoamine oxidase inhibitor. Called Emsam (selegiline), the patch can be used at its lowest dose without the dietary restrictions that accompany oral MAO inhibitors.
Mar 01, 2006